Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease
December 05, 2025 08:00 ET Â | Source: Amneal Pharmaceuticals LLC Interim data…
NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation
SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in…
Plume Appoints Lorie Boyd as Chief People Officer
Boyd brings deep HR and workforce management experience from Turo and Zendesk…
Yatra Strengthens Leadership for Next Phase of Growth
Elevates Co-Founder Dhruv Shringi to Executive Chairman; Appoints Siddhartha Gupta as CEONEW…
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE:…
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
November 26, 2025 19:00 ET Â | Source: HUTCHMED (China) Limited HONG KONG…
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Antibody levels remained well above baseline across all six serotypes and age…
Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov.…
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as…
GMR001 HYPERCAR TESTING REACHES NEW PHASE WITH FIRST PERFORMANCE AND WET WEATHER RUNNING
Testing of the GMR-001 Hypercar entered a new phase last week at…
